$1.26
−$0.02−1.56%
Delayed · · marketstack
3 open-market sales on file ($1.02M), none of them under a pre-arranged plan. Who, and when
+$0.22+21.15%over 1M
Price ÷ trailing earnings
No comments yet
Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.
Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.
Updated · the last close
What AIFF has filed with the SEC. This is not Firefly NEUROSCIENCE, Inc.’s own investor relations site: these filings are the primary source that site publishes from.
AIFF is among the largest companies matching:
The assistant answers from what AIFF has actually filed: 16 annual reports filed with the SEC and 12 Form 4 filings from the last year. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.
Press one and the answer appears right here on the page, from AIFF's filings and figures. One a day without an account; a free account has its own, and no card.
See how much of Firefly NEUROSCIENCE, Inc. each of these investors holds, and every quarter they moved.
Ten seconds. No card. Nothing to cancel.
Be told the moment a AIFF insider trades
Put Firefly NEUROSCIENCE, Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Firefly NEUROSCIENCE, Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Firefly NEUROSCIENCE, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.
Free, no card, and it does not expire.
From Item 1A of its most recent 10-K, filed March 2026.
And 20 more.
FDA approval
Risks Related to Legal, Regulatory and Compliance Matters Complying with regulations enforced by FDA and other regulatory authorities is expensive and time consuming, and failure to comply could result in substantial penalties. Our current and potentially …7 more themes are on Measure
Free, no card, and it does not expire. See what the paid plans add
16 more events are on Measure
Free, no card, and it does not expire. See what the paid plans add